Timothy Cragin Wang, MD, discusses the lack of response to checkpoint inhibitors in colorectal cancer.
Timothy Cragin Wang, MD
Advertisement
Articles by Timothy Cragin Wang, MD
Advertisement
Latest Updated Articles
Dr. Wang on Challenges With Checkpoint Inhibitors in CRCPublished: June 23rd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer
2
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
3
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
4
NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer
5